• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善2型糖尿病患者的治疗效果:应对临床挑战的实用解决方案。

Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challenges.

作者信息

Gavin James R, Stolar Mark W, Freeman Jeffrey S, Spellman Craig W

机构信息

Healing Our Village, Inc, Lanham, MD 20706-4393, USA.

出版信息

J Am Osteopath Assoc. 2010 May;110(5 Suppl 6):S2-14; quiz S15-6.

PMID:20554501
Abstract

The incidence and prevalence of type 2 diabetes mellitus (T2DM) in the United States continue to rise, and the disease has become an enormous health concern. While effective glycemic management reduces the risk of diabetes-related complications in patients with T2DM, many patients are unable to reduce their glucose levels to target goals. The authors review key elements in the management of T2DM with an emphasis on achieving and maintaining glycemic control. Strategies are offered to provide practical solutions to the challenges faced by healthcare providers and patients with T2DM. The importance of implementing evidence-based practice guidelines while empowering patients to participate in self-management of their disease is highlighted.

摘要

美国2型糖尿病(T2DM)的发病率和患病率持续上升,该疾病已成为一个巨大的健康问题。虽然有效的血糖管理可降低T2DM患者发生糖尿病相关并发症的风险,但许多患者无法将血糖水平降至目标值。作者回顾了T2DM管理的关键要素,重点是实现和维持血糖控制。文中提供了一些策略,以切实解决医疗服务提供者和T2DM患者所面临的挑战。强调了实施循证实践指南的重要性,同时让患者有能力参与自身疾病的自我管理。

相似文献

1
Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challenges.改善2型糖尿病患者的治疗效果:应对临床挑战的实用解决方案。
J Am Osteopath Assoc. 2010 May;110(5 Suppl 6):S2-14; quiz S15-6.
2
Control of postprandial glucose levels with insulin in type 2 diabetes.2 型糖尿病患者的胰岛素控制餐后血糖水平。
Postgrad Med. 2011 Jul;123(4):135-47. doi: 10.3810/pgm.2011.07.2313.
3
Type 2 diabetes mellitus: managing hemoglobin A(1c) and beyond.2型糖尿病:血红蛋白A(1c)的管理及其他
South Med J. 2010 Sep;103(9):911-6. doi: 10.1097/SMJ.0b013e3181eb34b2.
4
[Towards personalized treatment of type 2 diabetes].迈向2型糖尿病的个性化治疗
Ned Tijdschr Geneeskd. 2019 Jan 14;163:D3494.
5
Optimizing Insulin Therapy: Basal Insulin and Beyond.优化胰岛素治疗:基础胰岛素及其他
J Fam Pract. 2018 Oct;67(10 Suppl).
6
Risks and benefits of attaining HbA(1c) goals: examining the evidence.实现糖化血红蛋白(HbA₁c)目标的风险与益处:审视相关证据。
J Am Osteopath Assoc. 2010 Jul;110(7 Suppl 7):eS7-12.
7
Intensified glucose control in type 2 diabetes--whose agenda?2型糖尿病强化血糖控制——谁的议程?
Lancet. 2011 Apr 9;377(9773):1220-2. doi: 10.1016/S0140-6736(10)61112-9. Epub 2010 Nov 18.
8
Document on a comprehensive approach to type 2 diabetes mellitus.关于2型糖尿病综合治疗方法的文件。
Endocrinol Diabetes Nutr (Engl Ed). 2019 Aug-Sep;66(7):443-458. doi: 10.1016/j.endinu.2018.10.010. Epub 2019 Feb 28.
9
Update on the Canadian Diabetes Association 2008 clinical practice guidelines.《加拿大糖尿病协会2008年临床实践指南》更新内容
Can Fam Physician. 2009 Jan;55(1):39-43.
10
Guidelines ease up on glycemic control for some patients with type 2 diabetes.指南放宽了对部分2型糖尿病患者的血糖控制要求。
JAMA. 2012 Jun 6;307(21):2243-4. doi: 10.1001/jama.2012.5242.

引用本文的文献

1
Apolipoprotein E Gene Variation in Pakistani Subjects with Type 2 Diabetes with and without Cardiovascular Complications.载脂蛋白 E 基因变异在有和无心血管并发症的巴基斯坦 2 型糖尿病患者中的研究。
Medicina (Kaunas). 2024 Jun 10;60(6):961. doi: 10.3390/medicina60060961.
2
High atherogenic risk concomitant with elevated HbA1c among persons with type 2 diabetes mellitus in North Ethiopia.在埃塞俄比亚北部,2 型糖尿病患者的高致动脉粥样硬化风险与 HbA1c 升高有关。
PLoS One. 2022 Feb 1;17(2):e0262610. doi: 10.1371/journal.pone.0262610. eCollection 2022.
3
Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer's disease.
将心血管和脑血管疾病药物重新定位,以延缓阿尔茨海默病的发病和进展。
Arch Pharm Res. 2020 Sep;43(9):932-960. doi: 10.1007/s12272-020-01268-5. Epub 2020 Sep 9.
4
New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.新型抗糖尿病药物在治疗和/或预防轻度认知障碍和阿尔茨海默病方面的新观点和新可能。
Metab Brain Dis. 2018 Aug;33(4):1009-1018. doi: 10.1007/s11011-018-0227-1. Epub 2018 Apr 6.
5
Brain GLP-1/IGF-1 Signaling and Autophagy Mediate Exendin-4 Protection Against Apoptosis in Type 2 Diabetic Rats.脑 GLP-1/IGF-1 信号通路和自噬介导艾塞那肽对 2 型糖尿病大鼠细胞凋亡的保护作用。
Mol Neurobiol. 2018 May;55(5):4030-4050. doi: 10.1007/s12035-017-0622-3. Epub 2017 Jun 2.
6
The functional activity of hypothalamic signaling systems in rats with neonatal diabetes mellitus treated with metformin.用二甲双胍治疗的新生糖尿病大鼠下丘脑信号系统的功能活性
Dokl Biochem Biophys. 2016 Mar;467(1):95-8. doi: 10.1134/S1607672916020058. Epub 2016 May 20.
7
Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal.从糖尿病到阿尔茨海默病的分子与生化轨迹:批判性评估
World J Diabetes. 2015 Sep 25;6(12):1223-42. doi: 10.4239/wjd.v6.i12.1223.
8
Utilization of model-based meta-analysis to delineate the net efficacy of taspoglutide from the response of placebo in clinical trials.利用基于模型的荟萃分析,从临床试验中安慰剂的反应来描绘塔司葡萄糖的净疗效。
Saudi Pharm J. 2015 Jul;23(3):241-9. doi: 10.1016/j.jsps.2014.11.008. Epub 2014 Nov 24.
9
Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease - How Anti-Diabetics Could be a Solution for Dementia.胰岛素作为2型糖尿病与阿尔茨海默病之间的桥梁——抗糖尿病药物如何成为治疗痴呆症的解决方案。
Front Endocrinol (Lausanne). 2014 Jul 8;5:110. doi: 10.3389/fendo.2014.00110. eCollection 2014.